691 related articles for article (PubMed ID: 32460771)
1. Long non-coding RNAs towards precision medicine in gastric cancer: early diagnosis, treatment, and drug resistance.
Yuan L; Xu ZY; Ruan SM; Mo S; Qin JJ; Cheng XD
Mol Cancer; 2020 May; 19(1):96. PubMed ID: 32460771
[TBL] [Abstract][Full Text] [Related]
2. LncRNAs as potential diagnostic and prognostic biomarkers in gastric cancer: A novel approach to personalized medicine.
Fattahi S; Kosari-Monfared M; Golpour M; Emami Z; Ghasemiyan M; Nouri M; Akhavan-Niaki H
J Cell Physiol; 2020 Apr; 235(4):3189-3206. PubMed ID: 31595495
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of non-coding RNAs in gastric cancer: Pathogenesis and clinical implications.
Xie SS; Jin J; Xu X; Zhuo W; Zhou TH
World J Gastroenterol; 2016 Jan; 22(3):1213-23. PubMed ID: 26811659
[TBL] [Abstract][Full Text] [Related]
4. Non-coding RNAs underlying chemoresistance in gastric cancer.
Poursheikhani A; Bahmanpour Z; Razmara E; Mashouri L; Taheri M; Morshedi Rad D; Yousefi H; Bitaraf A; Babashah S
Cell Oncol (Dordr); 2020 Dec; 43(6):961-988. PubMed ID: 32495294
[TBL] [Abstract][Full Text] [Related]
5. Noncoding RNAs in gastric cancer: implications for drug resistance.
Wei L; Sun J; Zhang N; Zheng Y; Wang X; Lv L; Liu J; Xu Y; Shen Y; Yang M
Mol Cancer; 2020 Mar; 19(1):62. PubMed ID: 32192494
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNAs in anti-cancer drug resistance.
Chen QN; Wei CC; Wang ZX; Sun M
Oncotarget; 2017 Jan; 8(1):1925-1936. PubMed ID: 27713133
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential.
Matuszcak C; Haier J; Hummel R; Lindner K
World J Gastroenterol; 2014 Oct; 20(38):13658-66. PubMed ID: 25320504
[TBL] [Abstract][Full Text] [Related]
8. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
9. Induction/reversal of drug resistance in gastric cancer by non-coding RNAs (Review).
Chen C; Tang X; Liu Y; Zhu J; Liu J
Int J Oncol; 2019 May; 54(5):1511-1524. PubMed ID: 30896792
[TBL] [Abstract][Full Text] [Related]
10. Non-coding RNAs in gastric cancer.
Xie S; Chang Y; Jin H; Yang F; Xu Y; Yan X; Lin A; Shu Q; Zhou T
Cancer Lett; 2020 Nov; 493():55-70. PubMed ID: 32712234
[TBL] [Abstract][Full Text] [Related]
11. Methylation-mediated gene silencing as biomarkers of gastric cancer: a review.
Nakamura J; Tanaka T; Kitajima Y; Noshiro H; Miyazaki K
World J Gastroenterol; 2014 Sep; 20(34):11991-2006. PubMed ID: 25232236
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs in gastric cancer: Biomarkers and therapeutic targets.
Ghafouri-Fard S; Vafaee R; Shoorei H; Taheri M
Gene; 2020 Oct; 757():144937. PubMed ID: 32640300
[TBL] [Abstract][Full Text] [Related]
13. Noncoding RNAs in drug-resistant pancreatic cancer: A review.
Lin Z; Lu S; Xie X; Yi X; Huang H
Biomed Pharmacother; 2020 Nov; 131():110768. PubMed ID: 33152930
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-induced drug resistance in gastric cancer.
Dehghanzadeh R; Jadidi-Niaragh F; Gharibi T; Yousefi M
Biomed Pharmacother; 2015 Aug; 74():191-9. PubMed ID: 26349984
[TBL] [Abstract][Full Text] [Related]
15. The underlying mechanisms of non-coding RNAs in the chemoresistance of pancreatic cancer.
Xiong G; Feng M; Yang G; Zheng S; Song X; Cao Z; You L; Zheng L; Hu Y; Zhang T; Zhao Y
Cancer Lett; 2017 Jul; 397():94-102. PubMed ID: 28254409
[TBL] [Abstract][Full Text] [Related]
16. Non-coding RNAs in regulating gastric cancer metastasis.
Feng W; Ding Y; Zong W; Ju S
Clin Chim Acta; 2019 Sep; 496():125-133. PubMed ID: 31276633
[TBL] [Abstract][Full Text] [Related]
17. Novel biomarkers for the identification and targeted therapy of gastric cancer.
Liu L; Cao L; Gong B; Yu J
Expert Rev Gastroenterol Hepatol; 2015; 9(9):1217-26. PubMed ID: 26220043
[TBL] [Abstract][Full Text] [Related]
18. Non-coding RNAs in drug resistance of head and neck cancers: A review.
Dai F; Dai L; Zheng X; Guo Y; Zhang Y; Niu M; Lu Y; Li H; Hou R; Zhang Y; Wen S; Hu W; An C; Wu Y; Gao W
Biomed Pharmacother; 2020 Jul; 127():110231. PubMed ID: 32428836
[TBL] [Abstract][Full Text] [Related]
19. Long Noncoding RNAs: New Regulators of Resistance to Systemic Therapies for Gastric Cancer.
Sun W; Jiang C; Ji Y; Xiao C; Song H
Biomed Res Int; 2021; 2021():8853269. PubMed ID: 33506041
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNAs in recurrent ovarian cancer: Theranostic perspectives.
Bhardwaj V; Tan YQ; Wu MM; Ma L; Zhu T; Lobie PE; Pandey V
Cancer Lett; 2021 Apr; 502():97-107. PubMed ID: 33429007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
